Barings’s CONMED CNMD Stock Holding History

Barings’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-158,150	Closed	-$6.72M	–	927
2013 Q4	$6.72M	Sell	158,150 -44,500	-22%	-$1.69M	0.28%	77
2013 Q3	$6.89M	Buy	202,650 +32,500	+19%	+$1.06M	0.3%	70
2013 Q2	$5.32M	Buy	+170,150	New	+$5.52M	0.24%	89

Other funds holding CNMD

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barings's CNMD Position: Q1 2014 in Review

Barings sold out of CONMED (CNMD) in Q1 2014, closing a stake of 158,150 shares — an estimated $6.72M sold.

Barings first reported a position in CNMD in Q2 2013 and held it in 3 quarters. The position peaked at $6.89M in Q3 2013. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2014.

Barings reported no remaining CONMED position as of Q1 2014 after selling out during the quarter.
Barings sold 158,150 CONMED shares in Q1 2014, an estimated $6.72M.
Barings first reported a position in CONMED in Q2 2013 and held it in 3 quarters.
Barings's CONMED position peaked at $6.89M in Q3 2013.
173 funds tracked by Wall St. Rank held CONMED as of Q1 2014.

Based on Barings's 13F filing for Q1 2014, filed 12 May 2014.